1-7 of 7
Ryan D. Morin
Close
Sort by
Journal Articles

Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL

John R. Davies, Laura K. Hilton, Aixiang Jiang, Sharon Barrans, Catherine Burton, Peter W. M. Johnson, Andrew J. Davies, Ming-Qing Du, Reuben Tooze, Francesco Cucco, Matthew A. Care, Ryan D. Morin, Christian Steidl, Chulin Sha, David R. Westhead, David W. Scott
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6156–6162.
https://doi.org/10.1182/bloodadvances.2023010673
Published: 2023
Includes: Supplemental data
Journal Articles

Shared and distinct genetic features in human and canine B-cell lymphomas

Krysta Mila Coyle, Tiana Hillman, Matthew Cheung, Bruno M. Grande, Kevin R. Bushell, Sarah E. Arthur, Miguel Alcaide, Nicole Thomas, Kostiantyn Dreval, Stephanie Wong, Krishanna Campbell, Ryan D. Morin
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3404–3409.
https://doi.org/10.1182/bloodadvances.2021006429
Published: 2022
Includes: Supplemental data
Journal Articles

Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma

Chiara Pighi, Taek-Chin Cheong, Mara Compagno, Enrico Patrucco, Maddalena Arigoni, Martina Olivero, Qi Wang, Cristina López, Stephan H. Bernhart, Bruno M. Grande, Teresa Poggio, Fernanda Langellotto, Lisa Bonello, Riccardo Dall’Olio, Sandra Martínez-Martín, Luca Molinaro, Paola Francia di Celle, Jonathan R. Whitfield, Laura Soucek, Claudia Voena, Raffaele A. Calogero, Ryan D. Morin, Louis M. Staudt, Reiner Siebert, Alberto Zamò, Roberto Chiarle
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5239–5257.
https://doi.org/10.1182/bloodadvances.2021005682
Published: 2021
Includes: Supplemental data
Journal Articles

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

Clinical Trials & Observations
Malgorzata Nowicka, Laura K. Hilton, Margaret Ashton-Key, Chantal E. Hargreaves, Chern Lee, Russell Foxall, Matthew J. Carter, Stephen A. Beers, Kathleen N. Potter, Christopher R. Bolen, Christian Klein, Andrea Knapp, Farheen Mir, Matthew Rose-Zerilli, Cathy Burton, Wolfram Klapper, David W. Scott, Laurie H. Sehn, Umberto Vitolo, Maurizio Martelli, Marek Trneny, Christopher K. Rushton, Graham W. Slack, Pedro Farinha, Jonathan C. Strefford, Mikkel Z. Oestergaard, Ryan D. Morin, Mark S. Cragg
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2945–2957.
https://doi.org/10.1182/bloodadvances.2021004770
Published: 2021
Includes: Supplemental data
Journal Articles

Treating lymphoma is now a bit EZ-er

Clinical Trials & Observations
Ryan D. Morin, Sarah E. Arthur, Sarit Assouline
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2256–2263.
https://doi.org/10.1182/bloodadvances.2020002773
Published: 2021
Journal Articles

Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma

Christopher K. Rushton, Sarah E. Arthur, Miguel Alcaide, Matthew Cheung, Aixiang Jiang, Krysta M. Coyle, Kirstie L. S. Cleary, Nicole Thomas, Laura K. Hilton, Neil Michaud, Scott Daigle, Jordan Davidson, Kevin Bushell, Stephen Yu, Ryan N. Rys, Michael Jain, Lois Shepherd, Marco A. Marra, John Kuruvilla, Michael Crump, Koren Mann, Sarit Assouline, Joseph M. Connors, Christian Steidl, Mark S. Cragg, David W. Scott, Nathalie A. Johnson, Ryan D. Morin
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2886–2898.
https://doi.org/10.1182/bloodadvances.2020001696
Published: 2020
Includes: Supplemental data
Journal Articles

High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology

Lauren C. Chong, Susana Ben-Neriah, Graham W. Slack, Ciara Freeman, Daisuke Ennishi, Anja Mottok, Brett Collinge, Pau Abrisqueta, Pedro Farinha, Merrill Boyle, Barbara Meissner, Robert Kridel, Alina S. Gerrie, Diego Villa, Kerry J. Savage, Laurie H. Sehn, Reiner Siebert, Ryan D. Morin, Randy D. Gascoyne, Marco A. Marra, Joseph M. Connors, Andrew J. Mungall, Christian Steidl, David W. Scott
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2755–2765.
https://doi.org/10.1182/bloodadvances.2018023572
Published: 2018
Includes: Supplemental data